Cefmenoxime
| 220px | |
| Cefmenoxime
| |
| Systematic (IUPAC) name | |
| (6R,7R)-7-{[(2E)-2-(2-amino-1,3-thiazol-4-yl)- 2-methoxyimino-acetyl]amino}-3-[(1-methyltetrazol- 5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylic acid | |
| Identifiers | |
| CAS number | |
| ATC code | J01 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C16H17N9O5S3 |
| Mol. mass | 511.562 g/mol |
| Pharmacokinetic data | |
| Bioavailability | 100% (given IM) |
| Protein binding | 50% to 70% |
| Metabolism | Negligible |
| Half life | 1 hour |
| Excretion | Renal, unchanged |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Intramuscular, intravenous |
|
WikiDoc Resources for Cefmenoxime | |
|
Articles | |
|---|---|
|
Most recent articles on Cefmenoxime Most cited articles on Cefmenoxime | |
|
Media | |
|
Powerpoint slides on Cefmenoxime | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Cefmenoxime at Clinical Trials.gov Clinical Trials on Cefmenoxime at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Cefmenoxime
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Cefmenoxime Discussion groups on Cefmenoxime Patient Handouts on Cefmenoxime Directions to Hospitals Treating Cefmenoxime Risk calculators and risk factors for Cefmenoxime
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Cefmenoxime | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Cefmenoxime is a third-generation cephalosporin antibiotic.
External links
- DDB 30892
- Yokota N, Koguchi M, Suzuki Y, Fukayama S, Ishihara R, Deguchi K, Oda S, Tanaka S, Nakane Y, Fukumoto T (1995). "Antibacterial activities of cefmenoxime against recent fresh clinical isolates from patients in sinusitis". Jpn J Antibiot 48 (5): 602-9. PMID 7637194.
- Paladino J, Fell R (1994). "Pharmacoeconomic analysis of cefmenoxime dual individualization in the treatment of nosocomial pneumonia.". Ann Pharmacother 28 (3): 384-9. PMID 8193431.
- Duncker G, Reich U, Krausse R (1994). "Cefmenoxime in corneal organ culture.". Ophthalmologica 208 (5): 262-6. PMID 7816419.
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies